| Interactions between Xenobiotics and DME (XEOTIC)
|
| Fungicide(s), Herbicide(s) or Insecticide(s) |
| Herbicide |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Atrazine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00969
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Herbicide |
| DME Modulation |
Atrazine inhibits the expression of DME SOD1 |
[1] |
| Monomethylarsonic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00982
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Herbicide |
| DME Modulation |
Monomethylarsonic acid induces the drug-metabolizing activity of DME SOD1 |
[2] |
| Pesticide/Insecticide |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Decamethrin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01047
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Pesticide/Insecticide |
| DME Modulation |
Decamethrin inhibits the drug-metabolizing activity of DME SOD1 |
[3] |
| Dicrotophos |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01050
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Pesticide/Insecticide |
| DME Modulation |
Dicrotophos inhibits the expression of DME SOD1 |
[4] |
| Health or Environmental Toxicant(s) |
| Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 8 Xenobiotics
|
| Acrylamide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01187
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Acrylamide inhibits the expression of DME SOD1 |
[5] |
| Cadmium |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01503
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Cadmium inhibits the drug-metabolizing activity of DME SOD1 |
[6] |
| Chloropicrin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01247
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Chloropicrin up-regulates the expression of DME SOD1 |
[7] |
| Cordycepin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01259
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Cordycepin inhibits the expression of DME SOD1 |
[8] |
| Kaempferol |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01353
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Kaempferol induces the drug-metabolizing activity of DME SOD1 |
[9] |
| Nickel chloride |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01397
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Nickel chloride up-regulates the expression of DME SOD1 |
[10] |
| Okadaic acid |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01409
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Okadaic acid inhibits the expression of DME SOD1 |
[11] |
| Paraquat |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01422
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Paraquat inhibits the expression of DME SOD1 |
[12] |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Benzo(a)pyrene |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Carcinogen |
| DME Modulation |
Benzo(a)pyrene inhibits the drug-metabolizing activity of DME SOD1 |
[3] |
| Aflatoxin B1 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen-mycotoxin |
| DME Modulation |
Aflatoxin B1 up-regulates the expression of DME SOD1 |
[13] |
| Environmental Pollutant |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| Dichlorodiphenyl dichloroethylene |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00768
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Environmental Pollutant |
| DME Modulation |
Dichlorodiphenyl dichloroethylene induces the drug-metabolizing activity of DME SOD1 |
[14] |
| Glyphosate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01320
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Environmental Pollutant |
| DME Modulation |
Glyphosate inhibits the drug-metabolizing activity of DME SOD1 |
[15] |
| Hexyl cinnamic aldehyde |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00985
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Environmental Pollutant |
| DME Modulation |
Hexyl cinnamic aldehyde up-regulates the expression of DME SOD1 |
[16] |
| Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| CD-437 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
CD-437 inhibits the expression of DME SOD1 |
[17] |
| Natural Product(s), Extract(s) or Medicine(s) |
| Natural Mixture |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| Amphibole asbestos |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00995
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Mixture |
| DME Modulation |
Amphibole asbestos inhibits the drug-metabolizing activity of DME SOD1 |
[18] |
| Particulate matter |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00919
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Mixture |
| DME Modulation |
Particulate matter inhibits the expression of DME SOD1 |
[19] |
| Tobacco smoke pollution |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00821
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Mixture |
| DME Modulation |
Tobacco smoke pollution inhibits the drug-metabolizing activity of DME SOD1 |
[20] |
| Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Apocarotenal |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01523
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Apocarotenal inhibits the expression of DME SOD1 |
[21] |
| Plant Extract |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Grape seed proanthocyanidins |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00758
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Plant Extract |
| DME Modulation |
Grape seed proanthocyanidins inhibits the expression of DME SOD1 |
[22] |
| Plant extracts |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01574
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Plant Extract |
| DME Modulation |
Plant extracts up-regulates the expression of DME SOD1 |
[23] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 34 Xenobiotics
|
| Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Acetaminophen inhibits the drug-metabolizing activity of DME SOD1 |
[24] |
| Arsenic trioxide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00339
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Arsenic trioxide inhibits the drug-metabolizing activity of DME SOD1 |
[25] |
| Benzoyl peroxide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00389
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Benzoyl peroxide induces the drug-metabolizing activity of DME SOD1 |
[26] |
| Beta carotene |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00401
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Beta carotene inhibits the expression of DME SOD1 |
[21] |
| Bleomycin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00341
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Bleomycin induces the drug-metabolizing activity of DME SOD1 |
[27] |
| Bosentan |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00148
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Bosentan inhibits the expression of DME SOD1 |
[28] |
| Carmustine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00012
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Carmustine inhibits the drug-metabolizing activity of DME SOD1 |
[29] |
| Cisplatin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cisplatin induces the drug-metabolizing activity of DME SOD1 |
[30] |
| Clofibrate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00016
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Clofibrate inhibits the expression of DME SOD1 |
[31] |
| Cocaine hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00751
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cocaine hydrochloride inhibits the expression of DME SOD1 |
[32] |
| Copper |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00834
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Copper inhibits the drug-metabolizing activity of DME SOD1 |
[33], [34] |
| Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclosporine inhibits the expression of DME SOD1 |
[35] |
| Disulfiram |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00028
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Disulfiram up-regulates the expression of DME SOD1 |
[16] |
| Doxorubicin hydrochloride |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00292
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Doxorubicin hydrochloride induces the drug-metabolizing activity of DME SOD1 |
[27] |
| Epinephrine |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00265
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Epinephrine induces the drug-metabolizing activity of DME SOD1 |
[36] |
| Fulvestrant |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00147
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Fulvestrant up-regulates the expression of DME SOD1 |
[37] |
| Gallium nitrate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00136
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Gallium nitrate inhibits the expression of DME SOD1 |
[38] |
| Hydrogen peroxide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00388
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Hydrogen peroxide inhibits the drug-metabolizing activity of DME SOD1 |
[39], [40] |
| Hydroquinone |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00430
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Hydroquinone inhibits the drug-metabolizing activity of DME SOD1 |
[41] |
| Medroxyprogesterone acetate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00743
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Medroxyprogesterone acetate up-regulates the expression of DME SOD1 |
[42] |
| Mitomycin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00089
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Mitomycin up-regulates the expression of DME SOD1 |
[43] |
| Penicillamine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00257
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Penicillamine inhibits the drug-metabolizing activity of DME SOD1 |
[44] |
| Pioglitazone hydrochloride |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00319
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Pioglitazone hydrochloride up-regulates the expression of DME SOD1 |
[19] |
| Raloxifene hydrochloride |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00126
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Raloxifene hydrochloride up-regulates the expression of DME SOD1 |
[12] |
| Rosiglitazone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00380
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Rosiglitazone up-regulates the expression of DME SOD1 |
[45] |
| Trientine hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00332
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Trientine hydrochloride inhibits the drug-metabolizing activity of DME SOD1 |
[46] |
| Troglitazone |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00086
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Troglitazone inhibits the drug-metabolizing activity of DME SOD1 |
[47] |
| Undecylenic acid |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00426
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Undecylenic acid inhibits the expression of DME SOD1 |
[48] |
| Aclarubicin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00450
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Aclarubicin inhibits the drug-metabolizing activity of DME SOD1 |
[49] |
| Bezafibrate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00493
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Bezafibrate induces the drug-metabolizing activity of DME SOD1 |
[50] |
| Chlorobenzene |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00442
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Chlorobenzene induces the drug-metabolizing activity of DME SOD1 |
[51] |
| Dihydroartemisinin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00454
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Dihydroartemisinin induces the drug-metabolizing activity of DME SOD1 |
[52] |
| Linsidomine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01368
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Linsidomine inhibits the drug-metabolizing activity of DME SOD1 |
[53] |
| Thiostrepton |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01485
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Thiostrepton induces the drug-metabolizing activity of DME SOD1 |
[54] |
| Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| Fenretinide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00565
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Fenretinide induces the drug-metabolizing activity of DME SOD1 |
[55] |
| Resveratrol |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00568
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Resveratrol up-regulates the expression of DME SOD1 |
[56], [57] |
| Sulforafan |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01478
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Sulforafan up-regulates the expression of DME SOD1 |
[58] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
| Bisphenol A |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Bisphenol A induces the drug-metabolizing activity of DME SOD1 |
[59] |
| Camptothecin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00597
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Camptothecin induces the drug-metabolizing activity of DME SOD1 |
[60] |
| Carbon monoxide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00572
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Carbon monoxide inhibits the drug-metabolizing activity of DME SOD1 |
[61] |
| Ditiocarb |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00591
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Ditiocarb inhibits the drug-metabolizing activity of DME SOD1 |
[62] |
| Genistein |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00557
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Genistein up-regulates the expression of DME SOD1 |
[63] |
| Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
| Adenosine triphosphate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00535
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Adenosine triphosphate induces the drug-metabolizing activity of DME SOD1 |
[64] |
| Dinitrochlorobenzene |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00571
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Dinitrochlorobenzene up-regulates the expression of DME SOD1 |
[16] |
| Quercetin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00538
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Quercetin up-regulates the expression of DME SOD1 |
[65] |
| Sodium arsenite |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00632
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Sodium arsenite induces the drug-metabolizing activity of DME SOD1 |
[66] |
| Tetradecanoylphorbol acetate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00599
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Tetradecanoylphorbol acetate induces the drug-metabolizing activity of DME SOD1 |
[67], [68] |
| Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 6 Xenobiotics
|
| (+)-JQ1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00723
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug in Preclinical Study |
| DME Modulation |
(+)-JQ1 inhibits the expression of DME SOD1 |
[69] |
| Manumycin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00713
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug in Preclinical Study |
| DME Modulation |
Manumycin inhibits the drug-metabolizing activity of DME SOD1 |
[70] |
| Eugenol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00885
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
Eugenol inhibits the drug-metabolizing activity of DME SOD1 |
[71] |
| GW-7604 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01326
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
GW-7604 up-regulates the expression of DME SOD1 |
[37] |
| ICG-001 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01336
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
ICG-001 inhibits the expression of DME SOD1 |
[72] |
| K-7174 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01348
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
K-7174 inhibits the expression of DME SOD1 |
[73] |
| Drug Marketed but Withdrawn from Market |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Danthron |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00516
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Marketed but Withdrawn from Market |
| DME Modulation |
Danthron inhibits the drug-metabolizing activity of DME SOD1 |
[74] |
| Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| 9,10-phenanthrenequinone |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00871
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
9,10-phenanthrenequinone inhibits the drug-metabolizing activity of DME SOD1 |
[75] |
| Chlorite |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00807
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
Chlorite induces the drug-metabolizing activity of DME SOD1 |
[76] |
| Thioxotriazole copper(II) |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01081
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Investigative Agent |
| DME Modulation |
Thioxotriazole copper(II) up-regulates the expression of DME SOD1 |
[77] |
|
|
|
|
|
|